Intravesical Instillation of Botulinum Toxin Type A to Patients With Urge Urinary Incontinence
Intravesikal Instillation af Botulinum Toxin Type A Til Patienter Med Urge Urininkontinens
Sponsor: Glostrup University Hospital, Copenhagen
This PHASE1/PHASE2 trial investigates Urge Urinary Incontinence and is currently ongoing. Glostrup University Hospital, Copenhagen leads this study, which shows 6 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE1/PHASE2
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE1_PHASE2
First recorded
Jan 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Glostrup University Hospital, Copenhagen
For direct contact, visit the study record on ClinicalTrials.gov .